Group One Trading’s Genmab GMAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.31M Buy
48,700
+46,000
+1,704% +$1.38M ﹤0.01% 2458
2025
Q4
$83.2K Sell
2,700
-1,900
-41% -$59.2K ﹤0.01% 5150
2025
Q3
$141K Buy
4,600
+300
+7% +$7.31K ﹤0.01% 5013
2025
Q2
$88.8K Sell
4,300
-52,800
-92% -$1.08M ﹤0.01% 5076
2025
Q1
$1.12M Buy
+57,100
New +$1.2M ﹤0.01% 2361
2024
Q1
Sell
-300
Closed -$9.55K 7374
2023
Q4
$9.55K Sell
300
-2,700
-90% -$84.8K ﹤0.01% 6234
2023
Q3
$106K Buy
3,000
+2,800
+1,400% +$107K ﹤0.01% 4406
2023
Q2
$7.6K Sell
200
-4,800
-96% -$191K ﹤0.01% 6531
2023
Q1
$189K Buy
+5,000
New +$192K ﹤0.01% 3736
2022
Q2
Sell
-100
Closed -$4K 8058
2022
Q1
$4K Sell
100
-100
-50% -$3.43K ﹤0.01% 7534
2021
Q4
$8K Sell
200
-1,000
-83% -$41.7K ﹤0.01% 7455
2021
Q3
$52K Sell
1,200
-20,900
-95% -$938K ﹤0.01% 6514
2021
Q2
$902K Buy
22,100
+15,400
+230% +$594K ﹤0.01% 3537
2021
Q1
$220K Buy
+6,700
New +$252K ﹤0.01% 4928
2020
Q4
Sell
-19,300
Closed -$707K 6675
2020
Q3
$707K Buy
19,300
+6,300
+48% +$228K ﹤0.01% 2532
2020
Q2
$441K Buy
+13,000
New +$354K ﹤0.01% 2742
2020
Q1
Sell
-100
Closed -$2K 5436
2019
Q4
$2K Buy
+100
New +$2.18K ﹤0.01% 4896

Other funds holding GMAB

Group One Trading's GMAB Position: Q1 2026 in Review

Group One Trading reduced its Genmab (GMAB) stake by 21% in Q1 2026, selling an estimated $184K and leaving 23,352 shares worth $627K. The position accounts for ﹤0.01% of the portfolio, ranked #3136.

Group One Trading first reported a position in GMAB in Q4 2019 and has held it in 4 quarters since. The position peaked at $909K in Q4 2025. 273 funds tracked by Wall St. Rank hold GMAB as of Q1 2026.

  • Group One Trading held 23,352 shares of Genmab worth $627K as of Q1 2026.
  • Group One Trading sold 6,147 Genmab shares in Q1 2026, an estimated $184K.
  • Genmab made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #3136 holding.
  • Group One Trading first reported a position in Genmab in Q4 2019 and has held it in 4 quarters since.
  • Group One Trading's Genmab position peaked at $909K in Q4 2025.
  • 273 funds tracked by Wall St. Rank held Genmab as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.